Evonik buys US-based biotech firm Transferra Nanosciences

Acquisition will expand portfolio of Evonik's healthcare business line with liposomal formulation technologies for parenteral drugs

Transferra Nanosciences and Evonik officials signing the pact
Transferra Nanosciences and Evonik officials signing the pact
BS B2B Bureau Essen, Germany
Last Updated : Jun 30 2016 | 3:04 PM IST
German specialty chemicals company Evonik has acquired Transferra Nanosciences Inc (formerly known as Northern Lipids Inc), a biotechnology company based in Burnaby close to Vancouver (Canada), for an undisclosed price.
 
Transferra is a contract development and manufacturing organisation (CDMO) that provides services as well as products to biotechnology companies engaged in the development of pharmaceutical products, using the company’s unique expertise in liposomal drug delivery systems. The acquisition allows Evonik to further expand the portfolio of its heathcare business line in the area of parenteral drug delivery technologies and services.   
  
“This transaction reflects our continued commitment to growth in the healthcare area and in the drug delivery space in particular,” said Dr Reiner Beste, chairman of the Board of Management of Evonik Nutrition & Care GmbH.    
  
Transferra services include prototype identification, scale-up and process development, analytical support and qualification of methods, production of test articles for toxicology studies and cGMP manufacturing of clinical trial materials. In addition Transferra offers a range of benchtop LIPEX extruders, as well as custom-built LIPEX extruders for large scale manufacture of commercial drug products.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jun 30 2016 | 3:01 PM IST

Next Story